Skip to main content
Erschienen in: Maternal and Child Health Journal 4/2020

13.02.2020 | Brief Reports

Correlates of Pregnant Women’s Participation in a Substance Use Assessment and Counseling Intervention Integrated into Prenatal Care

verfasst von: Kelly C. Young-Wolff, Lue-Yen Tucker, Mary Anne Armstrong, Amy Conway, Constance Weisner, Nancy Goler

Erschienen in: Maternal and Child Health Journal | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Screening and referral for substance use are essential components of prenatal care. However, little is known about barriers to participation in substance use interventions that are integrated within prenatal care.

Methods

Our study examines demographic and clinical correlates of participation in an initial assessment and counseling intervention integrated into prenatal care in a large healthcare system. The sample comprised Kaiser Permanente Northern California pregnant women with a live birth in 2014 or 2015 who screened positive for prenatal substance use via a self-reported questionnaire and/or urine toxicology test given as part of standard prenatal care (at ~ 8 weeks gestation).

Results

Of the 11,843 women who screened positive for prenatal substance use (median age = 30 years; 42% white; 38% screened positive for alcohol only, 20% for cannabis only, 5% nicotine only, 17% other drugs only, and 19% ≥ 2 substance categories), 9836 (83%) completed the initial substance use assessment and counseling intervention. Results from multivariable logistic regression analyses indicated that younger age, lower income, single marital status, and a positive urine toxicology test predicted higher odds of participation, while other/unknown race/ethnicity, greater parity, receiving the screening later in pregnancy, and screening positive for alcohol only or other drugs only predicted lower odds of participation (all Ps < .05).

Discussion

Findings suggest that integrated substance use interventions can successfully reach vulnerable populations of pregnant women (e.g., younger, lower income, racial/ethnic minorities). Future research should address whether differences in participation are due to patient (e.g., type of substance used, perceived stigma) or provider factors (e.g., working harder to engage traditionally underserved patients).
Literatur
Zurück zum Zitat American College of Obstetricians Gynecologists Committee on Health Care for Undeserved Women. (2006). ACOG Committee Opinion No. 343: Psychosocial risk factors: Perinatal screening and intervention. Obstetrics and Gynecology,108, 469–477.CrossRef American College of Obstetricians Gynecologists Committee on Health Care for Undeserved Women. (2006). ACOG Committee Opinion No. 343: Psychosocial risk factors: Perinatal screening and intervention. Obstetrics and Gynecology,108, 469–477.CrossRef
Zurück zum Zitat Armstrong, M. A., Gonzales Osejo, V., Lieberman, L., Carpenter, D. M., Pantoja, P. M., & Escobar, G. J. (2003). Perinatal substance abuse intervention in obstetric clinics decreases adverse neonatal outcomes. Journal of Perinatology,23, 3–9.CrossRef Armstrong, M. A., Gonzales Osejo, V., Lieberman, L., Carpenter, D. M., Pantoja, P. M., & Escobar, G. J. (2003). Perinatal substance abuse intervention in obstetric clinics decreases adverse neonatal outcomes. Journal of Perinatology,23, 3–9.CrossRef
Zurück zum Zitat Armstrong, M. A., Lieberman, L., Carpenter, D. M., Gonzales, V. M., Usatin, M. S., Newman, L., et al. (2001). Early Start: An obstetric clinic-based, perinatal substance abuse intervention program. Quality Management in Health Care,9, 6–15.CrossRef Armstrong, M. A., Lieberman, L., Carpenter, D. M., Gonzales, V. M., Usatin, M. S., Newman, L., et al. (2001). Early Start: An obstetric clinic-based, perinatal substance abuse intervention program. Quality Management in Health Care,9, 6–15.CrossRef
Zurück zum Zitat Clark, K. A., Dee, D. L., Bale, P. L., & Martin, S. L. (2001). Treatment compliance among prenatal care patients with substance abuse problems. American Journal of Drug and Alcohol Abuse,27, 121–136.CrossRef Clark, K. A., Dee, D. L., Bale, P. L., & Martin, S. L. (2001). Treatment compliance among prenatal care patients with substance abuse problems. American Journal of Drug and Alcohol Abuse,27, 121–136.CrossRef
Zurück zum Zitat Committee on Obstetric Practice. (2017a). Committee opinion no. 711: Opioid use and opioid use disorder in pregnancy. Obstetrics and Gynecology,130, e81–e94.CrossRef Committee on Obstetric Practice. (2017a). Committee opinion no. 711: Opioid use and opioid use disorder in pregnancy. Obstetrics and Gynecology,130, e81–e94.CrossRef
Zurück zum Zitat Committee on Obstetric Practice. (2017b). Committee opinion no. 722: Marijuana use during pregnancy and lactation. Obstetrics and Gynecology,130, e205–e209.CrossRef Committee on Obstetric Practice. (2017b). Committee opinion no. 722: Marijuana use during pregnancy and lactation. Obstetrics and Gynecology,130, e205–e209.CrossRef
Zurück zum Zitat Corrarino, J. E., Williams, C., Campbell, W. S., Amrhein, E., LoPiano, L., & Kalachik, D. (2000). Linking substance-abusing pregnant women to drug treatment services: a pilot program. Journal of Obstetric, Gynecologic, and Neonatal Nursing,29, 369–376.CrossRef Corrarino, J. E., Williams, C., Campbell, W. S., Amrhein, E., LoPiano, L., & Kalachik, D. (2000). Linking substance-abusing pregnant women to drug treatment services: a pilot program. Journal of Obstetric, Gynecologic, and Neonatal Nursing,29, 369–376.CrossRef
Zurück zum Zitat Goler, N. C., Armstrong, M. A., Taillac, C. J., & Osejo, V. M. (2008). Substance abuse treatment linked with prenatal visits improves perinatal outcomes: a new standard. Journal of Perinatology,28, 597–603.CrossRef Goler, N. C., Armstrong, M. A., Taillac, C. J., & Osejo, V. M. (2008). Substance abuse treatment linked with prenatal visits improves perinatal outcomes: a new standard. Journal of Perinatology,28, 597–603.CrossRef
Zurück zum Zitat Goler, N. C., Armstrong, M. A., Osejo, V. M., Hung, Y. Y., Haimowitz, M., & Caughey, A. B. (2012). Early start: a cost-beneficial perinatal substance abuse program. Obstetrics and Gynecology,119, 102–110.CrossRef Goler, N. C., Armstrong, M. A., Osejo, V. M., Hung, Y. Y., Haimowitz, M., & Caughey, A. B. (2012). Early start: a cost-beneficial perinatal substance abuse program. Obstetrics and Gynecology,119, 102–110.CrossRef
Zurück zum Zitat Haller, D. L., Miles, D. R., & Dawson, K. S. (2003). Factors influencing treatment enrollment by pregnant substance abusers. American Journal of Drug and Alcohol Abuse,29, 117–131.CrossRef Haller, D. L., Miles, D. R., & Dawson, K. S. (2003). Factors influencing treatment enrollment by pregnant substance abusers. American Journal of Drug and Alcohol Abuse,29, 117–131.CrossRef
Zurück zum Zitat Haug, N. A., Duffy, M., & McCaul, M. E. (2014). Substance abuse treatment services for pregnant women: psychosocial and behavioral approaches. Obstetrics and Gynecology Clinics of North America,41, 267–296.CrossRef Haug, N. A., Duffy, M., & McCaul, M. E. (2014). Substance abuse treatment services for pregnant women: psychosocial and behavioral approaches. Obstetrics and Gynecology Clinics of North America,41, 267–296.CrossRef
Zurück zum Zitat Howell, E. M., & Chasnoff, I. J. (1999). Perinatal substance abuse treatment. Findings from focus groups with clients and providers. Journal of Substance Abuse Treatment,17, 139–148.CrossRef Howell, E. M., & Chasnoff, I. J. (1999). Perinatal substance abuse treatment. Findings from focus groups with clients and providers. Journal of Substance Abuse Treatment,17, 139–148.CrossRef
Zurück zum Zitat Jackson, A., & Shannon, L. (2012). Barriers to receiving substance abuse treatment among rural pregnant women in Kentucky. Maternal and Child Health Journal,16, 1762–1770.CrossRef Jackson, A., & Shannon, L. (2012). Barriers to receiving substance abuse treatment among rural pregnant women in Kentucky. Maternal and Child Health Journal,16, 1762–1770.CrossRef
Zurück zum Zitat Krans, E. E., Bobby, S., England, M., Gedekoh, R. H., Chang, J. C., Maguire, B., et al. (2018). The Pregnancy Recovery Center: A women-centered treatment program for pregnant and postpartum women with opioid use disorder. Addictive Behaviors,86, 124–129.CrossRef Krans, E. E., Bobby, S., England, M., Gedekoh, R. H., Chang, J. C., Maguire, B., et al. (2018). The Pregnancy Recovery Center: A women-centered treatment program for pregnant and postpartum women with opioid use disorder. Addictive Behaviors,86, 124–129.CrossRef
Zurück zum Zitat Messer, K., Clark, K. A., & Martin, S. L. (1996). Characteristics associated with pregnant women's utilization of substance abuse treatment services. American Journal of Drug and Alcohol Abuse,22, 403–422.CrossRef Messer, K., Clark, K. A., & Martin, S. L. (1996). Characteristics associated with pregnant women's utilization of substance abuse treatment services. American Journal of Drug and Alcohol Abuse,22, 403–422.CrossRef
Zurück zum Zitat Ordean, A., & Kahan, M. (2011). Comprehensive treatment program for pregnant substance users in a family medicine clinic. Canadian Family Physician,57, e430–435.PubMedPubMedCentral Ordean, A., & Kahan, M. (2011). Comprehensive treatment program for pregnant substance users in a family medicine clinic. Canadian Family Physician,57, e430–435.PubMedPubMedCentral
Zurück zum Zitat Paine, L. L., & Garceau, L. M. (1999). Health behaviors during pregnancy: risks and interventions. In M. C. McCormick & J. E. Siegel (Eds.), Prenatal care effectiveness and implementation (pp. 33–62). New York: Cambridge University Press.CrossRef Paine, L. L., & Garceau, L. M. (1999). Health behaviors during pregnancy: risks and interventions. In M. C. McCormick & J. E. Siegel (Eds.), Prenatal care effectiveness and implementation (pp. 33–62). New York: Cambridge University Press.CrossRef
Zurück zum Zitat Polakowski, L. L., Akinbami, L. J., & Mendola, P. (2009). Prenatal smoking cessation and the risk of delivering preterm and small-for-gestational-age newborns. Obstetrics and Gynecology,114, 318–325.CrossRef Polakowski, L. L., Akinbami, L. J., & Mendola, P. (2009). Prenatal smoking cessation and the risk of delivering preterm and small-for-gestational-age newborns. Obstetrics and Gynecology,114, 318–325.CrossRef
Zurück zum Zitat Salas-Wright, C. P., Vaughn, M. G., Ugalde, J., & Todic, J. (2015). Substance use and teen pregnancy in the United States: evidence from the NSDUH 2002–2012. Addictive Behaviors,45, 218–225.CrossRef Salas-Wright, C. P., Vaughn, M. G., Ugalde, J., & Todic, J. (2015). Substance use and teen pregnancy in the United States: evidence from the NSDUH 2002–2012. Addictive Behaviors,45, 218–225.CrossRef
Zurück zum Zitat Sutter, M. B., Gopman, S., & Leeman, L. (2017). Patient-centered care to address barriers for pregnant women with opioid dependence. Obstetrics and Gynecology Clinics of North America,44, 95–107.CrossRef Sutter, M. B., Gopman, S., & Leeman, L. (2017). Patient-centered care to address barriers for pregnant women with opioid dependence. Obstetrics and Gynecology Clinics of North America,44, 95–107.CrossRef
Zurück zum Zitat Sweeney, P. J., Schwartz, R. M., Mattis, N. G., & Vohr, B. (2000). The effect of integrating substance abuse treatment with prenatal care on birth outcome. Journal of Perinatology,20, 219–224.CrossRef Sweeney, P. J., Schwartz, R. M., Mattis, N. G., & Vohr, B. (2000). The effect of integrating substance abuse treatment with prenatal care on birth outcome. Journal of Perinatology,20, 219–224.CrossRef
Zurück zum Zitat Terplan, M., McNamara, E. J., & Chisolm, M. S. (2012). Pregnant and non-pregnant women with substance use disorders: The gap between treatment need and receipt. Journal of Addictive Diseases,31, 342–349.CrossRef Terplan, M., McNamara, E. J., & Chisolm, M. S. (2012). Pregnant and non-pregnant women with substance use disorders: The gap between treatment need and receipt. Journal of Addictive Diseases,31, 342–349.CrossRef
Zurück zum Zitat Young-Wolff, K. C., Tucker, L. Y., Alexeeff, S., Armstrong, M. A., Conway, A., Weisner, C., et al. (2017). Trends in self-reported and biochemically tested marijuana use among pregnant females in California from 2009–2016. JAMA,318, 2490–2491.CrossRef Young-Wolff, K. C., Tucker, L. Y., Alexeeff, S., Armstrong, M. A., Conway, A., Weisner, C., et al. (2017). Trends in self-reported and biochemically tested marijuana use among pregnant females in California from 2009–2016. JAMA,318, 2490–2491.CrossRef
Zurück zum Zitat Young-Wolff, K. C., Sarovar, V., Tucker, L. Y., Avalos, L. A., Conway, A., Armstrong, M. A., et al. (2018). Association of nausea and vomiting in pregnancy with prenatal marijuana use. JAMA Internal Medicine,178, 1423–1424.CrossRef Young-Wolff, K. C., Sarovar, V., Tucker, L. Y., Avalos, L. A., Conway, A., Armstrong, M. A., et al. (2018). Association of nausea and vomiting in pregnancy with prenatal marijuana use. JAMA Internal Medicine,178, 1423–1424.CrossRef
Zurück zum Zitat Young-Wolff, K. C., Sarovar, V., Tucker, L. Y., Avalos, L. A., Alexeeff, S., Conway, A., et al. (2019a). Trends in marijuana use among pregnant women with and without nausea and vomiting in pregnancy, 2009–2016. Drug and Alcohol Dependence,196, 66–70.CrossRef Young-Wolff, K. C., Sarovar, V., Tucker, L. Y., Avalos, L. A., Alexeeff, S., Conway, A., et al. (2019a). Trends in marijuana use among pregnant women with and without nausea and vomiting in pregnancy, 2009–2016. Drug and Alcohol Dependence,196, 66–70.CrossRef
Zurück zum Zitat Young-Wolff, K. C., Sarovar, V., Tucker, L. Y., Conway, A., Alexeeff, S., Weisner, C., et al. (2019b). Self-reported daily, weekly, and monthly cannabis use among women before and during pregnancy. JAMA Network Open,2, e196471.CrossRef Young-Wolff, K. C., Sarovar, V., Tucker, L. Y., Conway, A., Alexeeff, S., Weisner, C., et al. (2019b). Self-reported daily, weekly, and monthly cannabis use among women before and during pregnancy. JAMA Network Open,2, e196471.CrossRef
Metadaten
Titel
Correlates of Pregnant Women’s Participation in a Substance Use Assessment and Counseling Intervention Integrated into Prenatal Care
verfasst von
Kelly C. Young-Wolff
Lue-Yen Tucker
Mary Anne Armstrong
Amy Conway
Constance Weisner
Nancy Goler
Publikationsdatum
13.02.2020
Verlag
Springer US
Erschienen in
Maternal and Child Health Journal / Ausgabe 4/2020
Print ISSN: 1092-7875
Elektronische ISSN: 1573-6628
DOI
https://doi.org/10.1007/s10995-020-02897-4

Weitere Artikel der Ausgabe 4/2020

Maternal and Child Health Journal 4/2020 Zur Ausgabe